Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease-Reference-Cited by-同舟云学术

Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease

Published:2002-12 Issue:23 Volume:12 Page:3359-3362
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Slater Martin J.,Andrews David M.,Baker Graham,Bethell Susanne S.,Carey Seb,Chaignot Helene,Clarke Berwyn,Coomber Barry,Ellis Malcolm,Good Andrew,Gray Norman,Hardy George,Jones Paul,Mills Gail,Robinson Ed

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. World Health Organisation Weekly Epidemiological Record 1997, 72, 65.

2. Relation of hepatitis C virus to hepatocellular carcinoma

3. Early indicators of prognosis in fulmitant hepatic failure: an assessment of the King's criteria

4. Hepatitis C: The clinical spectrum of disease

5. Hepatitis C virus NS3/4A protease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation;Chemical Science;2024

2. Copper-Catalyzed Bisannulations of Malonate-Tethered O-Acyl Oximes with Pyridine, Pyrazine, Pyridazine, and Quinoline Derivatives for the Construction of Dihydroindolizine-Fused Pyrrolidinones and Analogues;Organic Letters;2021-11-01

3. Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies;RSC Advances;2020

4. In Silico Screening for Potent Anti-HCV Compounds with Inhibitory Activities Toward the NS3/4A Protease;International Journal of Peptide Research and Therapeutics;2018-08-21

5. Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection;Comprehensive Medicinal Chemistry III;2017